| Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads". |
2023-12-20 |
| Agilent Technologies Inc.. (12/20/23). "Press Release: Agilent Makes Strategic Updates to Organizational Structure". Santa Clara, CA. |
2023-12-20 |
| LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. |
2023-12-19 |
| CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen. |
2023-12-19 |
| Miltenyi Biotec B.V. & Co. KG. (12/18/23). "Press Release: Miltenyi Biotec and Replay’s Oncology-focused Product Company Syena Enter into Exclusive Licensing and GMP Manufacturing Agreement for PRAME TCR-NK Cell Therapy Based on CliniMACS Prodigy". Bergi |
2023-12-18 |
| BioNTech SE. (12/18/23). "Press Release: BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda". Kigali. |
2023-12-18 |
| SGS S.A.. (12/18/23). "Press Release: SGS Signs Agreement to Divest Crop Science Operations to Eurofins Scientific [ Ad hoc announcement pursuant to Art. 53 LR ]
". |
2023-12-18 |
| HealthTech For Care. (12/18/23). "Press Release: HealthTech For Care Makes Governance Changes, Appointing Pierre Courteille as Chairman and Sophie Villedieu as Managing Director". Paris. |
2023-12-18 |
| AC Immune S.A.. (12/15/23). "Press Release: AC Immune Announces Pricing of Underwritten Offering of Common Shares". Lausanne. |
2023-12-15 |
| AC Immune S.A.. (12/15/23). "Press Release: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO". Lausanne. |
2023-12-15 |
| DESY. (12/14/23). "Press Release: DESY and CrystalsFirst Team Up to Speed Up the Pre-clinical Drug Discovery Process". |
2023-12-14 |
| Vandria S.A.. (12/14/23). "Press Release: Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program and Mitochondrial Therapeutics Platform". Lausanne. |
2023-12-14 |
| Life Science Nord Management GmbH. (12/14/23). "Press Release: Dr. Jürgen Walkenhorst Is Leaving Life Science Nord". |
2023-12-14 |
| MorphoSys AG. (12/14/23). "Press Release: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million [Not for US, AU, ZA, JP, et al.]". Planegg. |
2023-12-14 |
| ITM Isotope Technologies Munich SE. (12/14/23). "Press Release: ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development and Commercialization of Folate-Based Radiotheranostics". Garching. |
2023-12-14 |
| InSphero AG. (12/14/23). "Press Release: InSphero Strengthens Its Executive Team by Appointing Paul Clémençon, MBA as Chief Business Officer". Zürich. |
2023-12-14 |
| EMBL. (12/14/23). "Press Release: Using Artificial Intelligence to Discover Therapeutic Antibodies". |
2023-12-14 |
| Sofinnova Partners. (12/13/23). "Press Release: Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups". Paris. |
2023-12-13 |
| Tome Biosciences, Inc.. (12/12/23). "Press Release: Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform". Watertown, MA. |
2023-12-12 |
| Zafrens. (12/11/23). "Press Release: Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale". San Diego, CA. |
2023-12-11 |
| Novogene. (12/8/23). "Press Release: Novogene Expands Its European Operations with New Genomics Facility at the IZB in Munich, Germany". Martinsried. |
2023-12-08 |
| Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA. |
2023-12-05 |
| Thermosome GmbH. (12/5/23). "Press Release: Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board". Munich. |
2023-12-05 |
| Eligo Bioscience S.A.. (12/5/23). "Press Release: Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines". Paris. |
2023-12-05 |
| Merck KGaA. (12/5/23). "Press Release: Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis". Darmstadt. |
2023-12-05 |
| IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". |
2023-12-05 |
| Merck KGaA. (12/4/23). "Press Release: Merck Strengthens Oncology Portfolio through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib [Not intended for UK-, US- or Canada-based media]". Darmstadt. |
2023-12-04 |
| Roche. (12/4/23). "Press Release: Roche Enters into a Definitive Merger Agreement to Acquire Carmot Therapeutics, including Three Clinical Stage Assets with Best-in-class Potential in Obesity and Diabetes". Basel. |
2023-12-04 |
| Heidelberg Pharma AG. (11/29/23). "Press Release: Heidelberg Pharma Announces Changes to the Executive Management Board. CEO Dr. Jan Schmidt-Brand to Retire". Ladenburg. |
2023-11-29 |
| WMT AG. (11/28/23). "Press Release: FS Investment Acquires a Stake in WMT AG". Düsseldorf & Heidelberg. |
2023-11-28 |
| Boehringer Ingelheim. (11/28/23). "Press Release: Boehringer Ingelheim and IBM Collaborate to Advance Generative AI and Foundation Models for Therapeutic Antibody Development". Ingelheim & Armonk, NY. |
2023-11-28 |
| Venture Kick. (11/23/23). "Press Release: Sallea Wins CHF 150,000 to Enable the Production of Fully Textured Animal Proteins". St. Gallen, Zürich & Lausanne. |
2023-11-23 |
| Evomedis GmbH. (11/23/23). "Press Release: Evomedis Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation". Graz. |
2023-11-23 |
| Boehringer Ingelheim. (11/22/23). "Press Release: Boehringer Ingelheim Expands Immuno-oncology Portfolio with the Acquisition of Bacterial Cancer Therapy Specialist T3 Pharma". Ingelheim & Basel. |
2023-11-22 |
| Merck KGaA. (11/21/23). "Press Release: Merck Expands Newest Biologics Testing Center in Shanghai". Shanghai. |
2023-11-21 |
| ECBF Management GmbH. (11/21/23). "Press Release: 17 Million Euros for Sustainable Agriculture. ECBF Leads RED Horticulture Series A Financing Round, Together with Demeter IM and Unigrains". Luxembourg. |
2023-11-21 |
| Swiss Centre for Applied Human Toxicology (SCAHT). (11/21/23). "Press Release: Prof Dr Ellen Fritsche Has Been Appointed as New Director of the Swiss Centre for Applied Human Toxicology (SCAHT)". |
2023-11-21 |
| Genentech, Inc.. (11/21/23). "Press Release: Genentech and Nvidia Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development". South San Francisco, CA. |
2023-11-21 |
| Evolva Holding S.A.. (11/21/23). "Press Release: Evolva Enters into an Agreement to Sell Its Operations to Lallemand, Securing the Best Possible Outcome for the Company and Its Stakeholders". Reinach. |
2023-11-21 |
| Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA. |
2023-11-21 |
| Medigene AG. (11/21/23). "Press Release: Medigene AG Announces Prioritization of Pipeline and Resource Allocation as Well as Extension of Cash Runway". Planegg. |
2023-11-21 |
| Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". |
2023-11-21 |
| Da Vinci Labs. (11/20/23). "Press Release: The European ‘SynBee Pitch Competition’ Will Reward Innovative Synthetic Biology Projects at SynBee Day 2024. Da Vinci Labs Is the New Coordinator of the SynBee Project". Reugny. |
2023-11-20 |
| Eli Lilly and Company. (11/17/23). "Press Release: Lilly Extends Tender Offer to Acquire Point Biopharma to Dec. 1, 2023". Indianapolis, IN. |
2023-11-17 |
| Eli Lilly and Company. (11/17/23). "Press Release: Lilly to Expand Injectable Manufacturing Capacity with Planned $2.5 Billion Site in Germany". Indianapolis, IN. |
2023-11-17 |
| Memo Therapeutics AG. (11/16/23). "Press Release: Memo Therapeutics AG Appoints Erik van den Berg as Chief Executive Officer". Schlieren. |
2023-11-16 |
| NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. |
2023-11-15 |
| Gilde Healthcare Partners. (11/15/23). "Press Release: Gilde Healthcare Closes New Venture&Growth Fund at €740 Million Hard Cap". Utrecht. |
2023-11-15 |
| Mainz Biomed N.V.. (11/15/23). "Press Release: Mainz Biomed Announces Closing of $5.0 Million Registered Direct Offering". Berkeley, CA & Mainz. |
2023-11-15 |
| Evolva Holding S.A.. (11/14/23). "Press Release: Evolva and Breko Broaden Partnership by Signing Agreement for the Exclusive Distribution of Veri-te Resveratrol in Germany, Austria, Thailand and Vietnam". Reinach. |
2023-11-14 |
| Merck KGaA. (11/14/23). "Press Release: Merck Announces Plans for New U.S. Healthcare Headquarters in Boston’s Seaport District [Not intended for US-based media]". Darmstadt. |
2023-11-14 |
| Glox Therapeutics Ltd.. (11/14/23). "Press Release: Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria". Glasgow. |
2023-11-14 |
| Nouscom AG. (11/14/23). "Press Release: Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round". Basel. |
2023-11-14 |
| Eckert & Ziegler AG. (11/14/23). "Press Release: Eckert & Ziegler Establishes German-Chinese Joint Venture with DC Pharma for the Production of Radioisotopes". Berlin. |
2023-11-14 |
| Legend Biotech Corporation. (11/13/23). "Press Release: Legend Biotech Announces Exclusive, Global License Agreement for Certain CAR-T Therapies Targeting DLL3". Somerset, NJ. |
2023-11-13 |
| Insempra GmbH. (11/10/23). "Press Release: Insempra Wins €1.5M Disruptive Innovation Grant with Circular Biomanufacturing Concept »BioTreasure«". Munich. |
2023-11-10 |
| Valneva S.E.. (11/10/23). "Press Release: Valneva Announces U.S. FDA Approval of World’s First Chikungunya Vaccine, Ixchiq". Saint Herblain. |
2023-11-10 |
| Mainz Biomed N.V.. (11/9/23). "Press Release: Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test". Berkeley, CA & Mainz. |
2023-11-09 |
| Valneva S.E.. (11/9/23). "Press Release: Valneva Reports Nine-Month 2023 Financial Results and Provides Corporate Updates". Saint Herblain. |
2023-11-09 |
| Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain. |
2023-11-07 |
| OpGen, Inc.. (11/7/23). "FORM 8-K: OpGen’s Wholly Owned Subsidiaries Curetis GmbH and Ares Genetics GmbH Filed for Bankruptcy Protection". |
2023-11-07 |
| Valanx Biotech GmbH. (11/7/23). "Press Release: Valanx Biotech Announces Successful Fundraise of 2.3 M EUR". Klosterneuburg. |
2023-11-07 |
| Biotheus Inc.. (11/6/23). "Press Release: Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications". Zhuhai. |
2023-11-06 |
| SolasCure Ltd.. (11/3/23). "Press Release: SolasCure Awarded Prestigious European Innovation Council’s Accelerator Grant". |
2023-11-03 |
| HeartBeat.bio AG. (11/02/23). "Press Release: HeartBeat.bio Raises € 4.5 Million in Pre-Series A Financing to Drive Development of Organoid Screening Platform for Cardiac Drug Discovery". Vienna. |
2023-11-02 |
| Immunic, Inc.. (11/2/23). "Press Release: Immunic Receives Notice of Allowance for United States Patent Protecting the Treatment of Relapsing Multiple Sclerosis with Vidofludimus and Its Salts". New York, NY. |
2023-11-02 |
| Memo Therapeutics AG. (11/02/23). "Press Release: Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients". Schlieren. |
2023-11-02 |
| Cambrium GmbH. (11/1/23). "Press Release: Cambrium Secures €8 Million in Seed Funding to Commercialize New Class of Performance Molecules". |
2023-11-01 |
| Cellbox Solutions GmbH. (11/1/23). "Press Release: Dr. Hartmut Tintrup Joins Cellbox Solutions GmbH as new CEO". Cologne. |
2023-11-01 |
| BioNTech SE. (10/31/23). "Press Release: BioNTech to Present Clinical and Preclinical Data Updates Across Multiple Immuno-Oncology Programs at 2023 SITC Annual Meeting". Mainz. |
2023-10-31 |
| Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.. |
2023-10-31 |
| Burning Rock Biotech Ltd.. (10/31/23). "Press Release: Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics". |
2023-10-31 |
| AATec Medical GmbH. (10/31/23). "Press Release: AATec Medical and Beurer Enter Development Collaboration for Inhaled Alpha-1 Antitrypsin". Munich. |
2023-10-31 |
| Merck KGaA. (10/30/23). "Press Release: Merck Strengthens Oncology Pipeline Through Strategic Partnership with Hengrui for Next-Generation Selective PARP1 Inhibitor and Antibody-Drug Conjugate [Not intended for US-, Canada- or UK-based media]". Darmstadt |
2023-10-30 |
| Roche. (10/30/23). "Press Release: Roche Announces EMBARK Trial in Duchenne Muscular Dystrophy (DMD) Did Not Reach Primary Endpoint, but Shows Positive Efficacy Outcomes on All Timed Functional Key Endpoints". Basel. |
2023-10-30 |
| MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY. |
2023-10-30 |
| Santhera Pharmaceuticals Holding AG. (10/27/23). "Press Release: Santhera Receives U.S. FDA Approval of AGAMREE® (vamorolone) for the Treatment of Duchenne Muscular Dystrophy [Ad hoc announcement pursuant to Art. 53 LR]". Pratteln. |
2023-10-27 |
| Mainz Biomed N.V.. (10/26/23). "Press Release: Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations". Berkeley, CA & Mainz. |
2023-10-26 |
| Simbec-Orion. (10/26/23). "Press Release: Simbec-Orion and biotx.ai Launch Strategic Partnership to De-risk Early-stage Drug Development with AI Supported Clinical Trial Design". London. |
2023-10-26 |
| Paion AG. (10/26/23). "Press Release: Filing an Application for the Opening of Insolvency Proceedings [ad hoc]". Aachen. |
2023-10-26 |
| MetrioPharm AG. (10/25/23). "Press Release: MetrioPharm Receives Rare Pediatric Disease Designation (RPDD) for MP1032 from the U.S. FDA". Zurich. |
2023-10-25 |
| Valneva S.E.. (10/25/23). "Press Release: Valneva Submits Chikungunya Vaccine Marketing Application to EMA and Announces CHMP Accelerated Assessment". Saint Herblain. |
2023-10-25 |
| Immatics N.V.. (10/24/23). "Press Release: Immatics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ACTengine® IMA203 TCR-T Monotherapy". Houston, TX & Tübingen. |
2023-10-24 |
| Roche. (10/23/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire Telavant". Basel. |
2023-10-23 |
| High-Tech Gründerfonds Management GmbH. (10/23/23). "Press Release: FarmInsect Raises Oversubscribed €8m Series A to Commercially Scale Its Insect Farming Technology". Munich. |
2023-10-23 |
| Dren Bio, Inc.. (10/23/23). "Press Release: Dren Bio Strengthens Leadership Team with Appointment of Amit Mehta, Ph.D., as Chief Operating Officer and Chief Business Officer". Foster City, CA. |
2023-10-23 |
| CMBlu Energy AG. (10/23/23). "Press Release: Technology Group STRABAG Invests 100 Million Euros into Battery and Energy Storage Company CMBlu Energy". Alzenau. |
2023-10-23 |
| 4SC AG. (10/18/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL in the European Union". Planegg-Martinsried. |
2023-10-18 |
| 4D Lifetec AG. (10/18/23). "Press Release: 4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection". Zürich & Cham. |
2023-10-18 |
| BioCopy AG. (10/17/23). "Press Release: BioCopy and Yumab Announce Partnership for Development of Innovative safeTY-engager Platform". Emmendingen & Braunschweig. |
2023-10-17 |
| Biotech Austria. (10/17/23). "Press Release: Inaugural Biotech Summit Austria Sets the Agenda for Emerging Biotech Innovation". Graz. |
2023-10-17 |
| SpliceBio S.L.. (10/17/23). "Press Release: SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease". Barcelona. |
2023-10-17 |
| CombiGene AB. (10/14/23). "Press Release: Spark Therapeutics Terminates Collaboration Agreement for the Epilepsy Project CG01 with CombiGene". Stockholm. |
2023-10-14 |
| MediLink Therapeutics (Suzhou) Co., Ltd.. (10/12/23). "Press Release: MediLink Therapeutics Announces Strategic Collaboration and Worldwide License Agreement with BioNTech to develop next-generation anti-cancer antibody-drug conjugate". Suzhou. |
2023-10-12 |
| Campus Berlin-Buch GmbH. (10/11/23). "Press Release: Boost for Berlin’s Biotech Sector. Campus Berlin-Buch Has a New Start-up Center". |
2023-10-11 |
| Eppendorf SE. (10/11/23). "Press Release: Eppendorf Realigns Management Board Structure. Eppendorf SE Returns to a Structure with Only One CEO". Hamburg. |
2023-10-11 |
| BioLizard N.V.. (10/11/23). "Press Release: BioLizard Launches New AI-empowered “BioVerse” Platform to Facilitate Data-driven R&D for Global Life Sciences Community". Ghent. |
2023-10-11 |
| Lead Discovery Center GmbH. (10/11/23). "Press Release: LDC and JT Team Up for the Discovery of New Therapies". Dortmund. |
2023-10-11 |
| Bayer AG. (10/10/23). "Press Release: Bayer Invests 250 million USD in New Cell Therapy Manufacturing Facility in the U.S. [Not intended for US and UK Media]". Berlin. |
2023-10-10 |
| Sidekick Health. (10/10/23). "Press Release: Sidekick Health Announces Landmark Acquisition, Expanding Its Portfolio to Offer Regulated Prescription Digital Therapeutics". Las Vegas. |
2023-10-10 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 5 6 ... 37 38 39 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
